Published by Shah Teelani & Associates | PCAOB-Registered Audit Firm | Reg. No. 7161
The Asia-to-US IPO pathway looks fundamentally different in 2026 than it did two years ago. New exchange rules are in force. A landmark cross-border listing framework launched in June. Scrutiny of foreign issuers has intensified at both the SEC and Nasdaq levels. At the same time, capital formation across Asia Pacific reached levels not seen in years. That combination creates a large and motivated pipeline of companies exploring US public markets.
Understanding the current landscape is not optional for any company evaluating a US listing. The rules are different. The timelines are longer. The documentation requirements are more demanding. Therefore, the first decision every company must make — selecting a PCAOB-registered auditor — also determines whether every other part of the listing process can proceed on schedule.
This post maps the key developments shaping the Asia-to-US listing environment in 2026. It explains what those developments mean for companies targeting Q4 2026 or Q1 2027 listings. September is the critical decision month. Here is why.
The APAC IPO Surge: What $90 Billion in 2025 Signals
Asia Pacific IPO activity surged to $90 billion in 2025. APAC became the largest contributor to global IPO proceeds for the year. According to J.P. Morgan’s Asia Pacific Equity Capital Markets Outlook, APAC accounted for over a third of total global equity capital market volumes. EY’s Global IPO Trends report confirmed the scale: APAC captured 43% of global IPO proceeds in 2025, with a 106% surge compared to 2024.
Hong Kong’s recovery was the defining story. HKEX recorded 119 IPOs raising more than HK$285.8 billion in 2025. That figure allowed HKEX to surpass both the NYSE and Nasdaq as the top listing destination for Chinese companies during the year. India sustained its position as the world’s most active IPO market by deal count. Southeast Asia saw a 76% increase in IPO proceeds to US$6.5 billion, driven by larger transactions in Singapore, Vietnam, the Philippines, and Malaysia.
Why the Surge Matters for US Listing Plans
The surge matters for US listing plans in two specific ways. First, companies that listed in regional markets now have audited financial history and investor-facing disclosure experience. That foundation makes a cross-listing or uplisting to a US exchange more credible and more achievable on a compressed timeline.
Second, the surge produced a large cohort of companies that deferred a US listing in 2025. Regional markets absorbed capital efficiently. Furthermore, Nasdaq’s new listing rules were still under SEC review. Many of those companies now re-evaluate their options. The Q1 2027 listing window is directly in their sights.
New Nasdaq Listing Rules: The $15 Million Public Float Standard
The regulatory changes at Nasdaq are not proposals. Most are now operative. Companies and their advisors must understand the current landscape precisely — not a pre-amendment version of the rules.
The first significant change took effect on January 17, 2026. The SEC approved Nasdaq’s amendments to its net income standard for initial listings in December 2025. Under the revised rules, companies listing on the Nasdaq Global Market or Nasdaq Capital Market under the net income standard must demonstrate a minimum market value of unrestricted publicly held shares of $15 million. This replaced the previous thresholds of $8 million for the Global Market and $5 million for the Capital Market.
Unrestricted publicly held shares exclude holdings by officers, directors, and 10% shareholders. They also exclude shares subject to resale restrictions. For IPOs, Nasdaq reviews shares sold in the offering to assess liquidity — not insider holdings. This distinction matters for structuring the offering size and float from the outset.
The $25 Million Rule for China-Based Companies
The second change has the most direct impact on Asian companies. It became operative on June 14, 2026. The SEC approved Nasdaq Rule 5210(l) on May 14, 2026, after Nasdaq first proposed it in September 2025. The rule requires companies primarily operating in China, including Hong Kong and Macau, to raise at least $25 million in gross proceeds from US public holders in a firm commitment underwritten IPO.
The rule applies not only to traditional IPOs. It also covers listings via de-SPAC transactions, direct listings, and uplistings from the OTC market or another national exchange. For business combination listings, the minimum market value of unrestricted publicly held shares must be at least $25 million following the transaction. Additionally, China-based companies can no longer pursue direct listings on the Nasdaq Global Market or Nasdaq Capital Market. Only the Nasdaq Global Select Market remains available for direct listings, and it carries substantially higher entry standards.
Accelerated Delisting and Nasdaq’s New Discretionary Authority
The third change affects continued listing compliance. Nasdaq adopted an accelerated suspension and delisting process for companies with a listing deficiency. Specifically, companies with a market value of listed securities below $5 million now face immediate suspension and delisting. The prior rules granted a compliance period before any suspension action. That grace period no longer exists below the $5 million MVLS threshold.
This is a continued listing rule, but its existence shapes IPO planning. Companies that list with minimal public float face a much shorter runway to correct any post-listing compliance deficiency. Therefore, deal structuring must account for post-listing float sustainability — not only the initial listing threshold.
Nasdaq also adopted new interpretive material — IM-5101-3 — effective December 19, 2025. This provision gives Nasdaq discretionary authority to deny an initial listing even when a company meets all stated quantitative requirements. Nasdaq may consider a company’s location, ownership structure, and the background of its advisors — including auditors, underwriters, and counsel. Moreover, it may consider the risk that a company’s stock could attract manipulative trading by unaffiliated third parties. Companies in the listing process in late 2025 already experienced delays as Nasdaq exercised this authority. For companies with complex ownership structures or advisors with prior compliance issues, this provision adds a layer of diligence that did not formally exist before.
The SGX-Nasdaq Global Listing Board: Structure and Eligibility
On June 29, 2026, the Securities and Futures (Amendment) Act 2026 and the Global Listing Board Rules took effect in Singapore. SGX and Nasdaq announced the framework in November 2025. A public consultation process concluded in April 2026. The Global Listing Board creates a direct and harmonized pathway for companies to simultaneously list on both Nasdaq and the Singapore Exchange. Companies use a single set of offering documents and a simplified review process by SGX.
The Global Listing Board targets companies with a market capitalization of at least S$2 billion — approximately US$1.5 billion — with an Asian nexus. Eligible companies include debut issuers listing on the Nasdaq Global Select Market and existing Nasdaq-listed issuers with the scale to satisfy the threshold. The framework requires a minimum allocation of 15% of IPO proceeds or S$75 million — whichever is higher — to the Singapore tranche.
What the GLB Means in Practice
The practical significance of the Global Listing Board is twofold. First, it eliminates the need for two separate prospectuses and two separate regulatory review processes. That alone reduces the cost and timeline of a dual listing materially. Second, it provides institutional asset owners and managers in Singapore with structured access to companies that might otherwise have listed only in the US.
The eligibility threshold is the primary constraint. At S$2 billion minimum market capitalization, the GLB targets institutional-quality companies — not smaller issuers. Southeast Asian companies like Carro and Carsome represent the profile the framework targets: well-known companies with institutional backing and realistic valuations above the threshold. For smaller APAC companies evaluating a US listing, the direct Nasdaq route remains the primary pathway. In that case, the updated listing standards described above apply in full.
What These Changes Mean for Your Listing Timeline
The combined effect of new Nasdaq listing standards, expanded Nasdaq discretionary authority, and the GLB framework is a more demanding and more differentiated listing environment. Not every company faces the same constraints. However, every company planning a US listing must map its specific situation against the current rules before committing to a timeline.
For companies headquartered or primarily operating in mainland China, Hong Kong, or Macau, the $25 million gross proceeds minimum is a hard floor. A company that cannot raise at least $25 million from US public holders in a firm commitment underwritten IPO cannot list on Nasdaq under Rule 5210(l). This eliminates many smaller listings that were feasible under the prior framework. Consequently, deal structuring — underwriter selection, offering size, pricing strategy — must target the threshold from US public holders specifically, not just in aggregate.
Qualitative Factors Now Carry Formal Weight
For companies from India, Southeast Asia, Korea, Japan, and other APAC markets not classified as China-based issuers, the $15 million MVUPHS threshold applies. More significantly, Nasdaq’s expanded discretionary authority under IM-5101-3 means that qualitative factors now carry formal weight in the listing review process. Selecting advisors with clean regulatory track records is no longer merely a best practice. It is a listing risk factor that Nasdaq can consider explicitly.
The Timeline: What Q4 2026 and Q1 2027 Actually Require
A company targeting a Q4 2026 listing needs a registration statement on file with the SEC by approximately October. That registration statement must include audited financial statements signed by a PCAOB-registered auditor. Audit work for a December 31, 2025 fiscal year end must be complete. The issuer must also have completed its legal restructuring, obtained necessary regulatory approvals, and engaged an underwriter.
In practice, all of these steps require lead times of six to twelve months from commencement. A Q1 2027 listing is achievable for companies that begin their IPO preparation in earnest in September 2026. Starting in October makes the calendar very tight. Starting after that, Q2 2027 becomes the realistic target. Every month of delay translates directly into a longer listing timeline. The audit engagement is the longest and least compressible element in the sequence.
September Is the Critical Decision Month
September 2026 is the inflection point for companies targeting a listing before mid-2027. The fall IPO window on US markets is historically the most active of the year. Institutional investor appetite is high coming out of summer. SEC review timelines are relatively predictable. Therefore, companies that enter the process in September with their preparation in place can target this window. Companies that begin in November are already planning for 2027 at the earliest.
The decisions that must be made in September are foundational. Legal counsel selection, underwriter engagement, and PCAOB-registered auditor selection must all be resolved before meaningful preparation can begin. The auditor cannot be switched mid-process without significant delays and cost. The underwriter cannot underwrite a registration statement without audited financial statements. Legal counsel cannot draft a prospectus without understanding the audit scope and timeline.
The Regulatory Picture Is Now Clear
September is also the month when companies that have monitored the evolving regulatory environment must make a definitive judgment about their listing route. The Nasdaq rules are settled. The GLB framework is live. The SEC’s Cross-Border Task Force is active. The qualitative factors that Nasdaq weighs under IM-5101-3 are publicly described. No further regulatory clarity will arrive before the Q4 2026 or Q1 2027 windows open. The landscape is known. The decision is whether to move.
The First Decision: Selecting a PCAOB-Registered Auditor
Every element of the US listing process depends on audited financial statements signed by a PCAOB-registered auditor. The SEC will not declare a registration statement effective without them. Nasdaq will not approve an initial listing application without them. No underwriter will proceed to roadshow without them. The audit is the foundation on which every other professional’s work is built.
A PCAOB-registered auditor must hold a current registration with the Public Company Accounting Oversight Board. The firm must conduct the engagement under PCAOB auditing standards and must be subject to PCAOB inspection. Registration alone is not sufficient. The auditor must also have demonstrated capacity to conduct a public company audit under US GAAP and PCAOB standards. For issuers with subsidiaries or operations across multiple jurisdictions, the auditor must also coordinate a group audit engagement that meets AS 2101 requirements.
Why Starting the Auditor Search Early Matters
Audit firms do not have unlimited capacity. PCAOB-registered firms with public company audit experience — particularly those serving OTC and Nasdaq-listed clients from Asia — are not interchangeable with domestic firms that have no international engagement experience. The right auditor for an Asian company listing in the US understands both the company’s operating environment and the SEC and PCAOB requirements that govern the audit.
Finding that firm, completing conflicts checks, negotiating the engagement letter, and beginning preliminary audit work all take time. Starting in September allows all of that to happen before year-end. Starting later puts the entire timeline at risk. Therefore, the auditor selection is not a task to schedule after the underwriter is engaged. It is the first task.
A Note on China-Based Issuers and PCAOB Inspection Access
For companies outside China, the auditor selection question is straightforward: find a PCAOB-registered firm with public company audit experience and the capacity to take on the engagement. For China-based companies, the auditor selection carries one additional consideration.
PCAOB inspection access to audit firms operating in mainland China has been a persistent regulatory issue. Companies should confirm that their prospective auditor’s PCAOB registration is in good standing. They should also confirm that the firm’s engagement files for China-based clients are fully subject to PCAOB inspection under the current framework.
Shah Teelani & Associates (PCAOB Reg. No. 7161) conducts PCAOB audit engagements for OTC and Nasdaq-listed public companies. Our clients include companies with operations across Asia, the Middle East, and North America. Our team has direct experience with SEC reporting requirements, PCAOB auditing standards, and the US GAAP technical accounting issues most relevant to Asian companies entering US public markets — including ASC 280, 260, 740, 606, 805, and 830.
The Bottom Line for CEOs, CFOs, and IPO Advisors
The 2026 Asia-to-US IPO landscape is more structured and more rule-bound than it was in 2024. The APAC IPO surge created a large pipeline of qualified candidates. New Nasdaq listing standards filtered out the smallest and most speculative issuers. The SGX-Nasdaq Global Listing Board opened a streamlined dual-listing pathway for the largest and most institutional-quality companies. Companies that list successfully in this environment treat the regulatory requirements as constraints to be met precisely — not obstacles to navigate loosely.
The first decision is the auditor. It is also the most time-sensitive decision. Everything else follows. Companies that make that decision in September 2026 are in a position to execute a Q4 2026 or Q1 2027 listing. Companies that defer it are planning for later.
Shah Teelani & Associates (PCAOB Reg. No. 7161) works with Asian companies and their IPO advisors at the earliest stage of the US listing process. We welcome direct conversations with CEOs, CFOs, and merchant bankers evaluating their options.
If your company or your client evaluates a US listing for Q4 2026 or Q1 2027, we are available to discuss audit scope, timeline, and engagement structure. Reach out to begin that conversation.
